Fig. 3From: Analysis of patients scheduled for neoadjuvant therapy followed by surgery for esophageal cancer, who never made it to esophagectomyOverall survival in the NT+S and NT−S cohorts, divided into the 2 time frames (2002–2010 and 2011–2015). NT+S neoadjuvant treatment plus surgery, NT−S neoadjuvant treatment without surgeryBack to article page